S1636 FRACTIONATED DOSING OF ARI-0001 CELLS (A3B1:CD8:4–1BB:CD3Z CAR19) AND EARLY TOCILIZUMAB ADMINISTRATION MAY REDUCE THE INCIDENCE OF SEVERE CYTOKINE RELEASE SYNDROME IN PATIENTS WITH CD19+ MALIGNANCIES

Authors :: E. Trias
M. Juan
A. Urbano-Ispizua
Montserrat Torrebadell
J. Esteve
Miguel Caballero-Baños
T. Baumann
Miguel Lozano
J. Delgado
A. Boronat
Anna Alonso-Saladrigues
M. Rovira
Y. Jordan
Albert Català
S. Pont
E. Garcia-Rey
S. Fernández
J.M. Canals
B. Marzal
J. Cid
D.F. Moreno
P. Castro
C. Llanos
M. Castella
F. Ramos
Jordi Yagüe
Valentín Ortiz-Maldonado
S. Rives
M. Díaz-Beyá
Source :: HemaSphere. 3:756
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: medicine.medical_specialty
biology
business.industry
Incidence (epidemiology)
Hematology
medicine.disease
Gastroenterology
CD19
chemistry.chemical_compound
Cytokine release syndrome
Tocilizumab
chemistry
Internal medicine
medicine
biology.protein
In patient
Dosing
business
CD8

Full Text Access

Tools